Navigation Links
Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
Date:5/11/2009

Real-time PCR test validated using clinical specimens confirmed

positive for Influenza A H1N1 Swine-origin flu virus

MADISON, N.J., May 11 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Focus Diagnostics infectious disease reference laboratory has introduced a laboratory-developed real-time polymerase chain reaction (PCR) test to aid in identifying Influenza A H1N1 Swine-origin (H1N1) flu virus ("S-OIV" or "novel H1N1"), also known as the Swine Flu. The Focus Diagnostics Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test is the first laboratory testing service to be introduced by a commercial laboratory to aid in the identification of patients infected with the novel H1N1 virus and differentiate patients infected with other seasonal Influenza A strains. Focus Diagnostics has a track record of being first to market with new laboratory testing services for emerging infectious diseases, such as West Nile Virus, SARS, and chikungunya virus.

"Our new laboratory test will be an important tool to help health care professionals and public health authorities identify infected patients more quickly, promoting earlier diagnosis and treatment," said Jon R. Cohen, M.D., senior vice president and chief medical officer, Quest Diagnostics. "This capability could be particularly important if the novel H1N1 virus continues to spread in the U.S. or re-emerges this fall or winter. Public health officials in the U.S. have done an exceptional job of managing the current Influenza emergency, and we continue to work closely with them to assist their preparedness efforts."

Focus Diagnostics validated its new Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test using clinical specimens submitt
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
2. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
3. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
4. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
5. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
6. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
7. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
8. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
9. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
10. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
11. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... July 31, 2015  Boston Children,s Hospital physicians ... 3D printing of their anatomy before undergoing high-risk ... malformations (abnormalities in the brain,s blood vessels) that ... today in the Journal of Neurosurgery: Pediatrics ... printing and synthetic resins to create custom, high-fidelity ...
(Date:7/31/2015)... , July 31, 2015 According ... by Product (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, ... End User (Hospitals, Pharmaceuticals) - Global Forecast to 2020", published ... around USD 6.1 Billion by 2020, at a CAGR of ... 242 market data T ables and ...
(Date:7/31/2015)... 31, 2015  Xcelience, a contract development and ... made a structured cash investment in Powdersize, a ... milling, micronization and powder size classification within the ... business while simultaneously adding a complete set of ... capabilities. "As we continue to ...
Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3
... key role in treatment discovery, MELBOURNE, Australia, ... Cytopia Limited (ASX: CYT) announced today that its ... in cells,isolated from patients with myeloproliferative disorders (MPDs)., ... there is over-production of,particular cells within the blood ...
... Tigris Pharmaceuticals,Inc., a privately held drug development company, ... study of aminoflavone,pro-drug (AFP-464) for the treatment of ... and enrollment is ongoing., The primary objectives ... limiting,toxicity (DLT) and maximum tolerated dose (MTD) of ...
Cached Medicine Technology:JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients 2Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 2Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 3
(Date:7/31/2015)... ... 2015 , ... The Heart Fit Clinic has increased a patient's fitness level ... of 150 beats versus 100 beats, this is a big deal," says Diamond Fernandes, ... back to patients with heart disease," he adds. People with angina are able to ...
(Date:7/31/2015)... Birmingham, AL (PRWEB) , ... July 31, 2015 , ... ... Legion Field in Birmingham. The U.S. Women's National Soccer Team will face the ... take place on Thursday, September 17th at Ford Field in Detroit and the second ...
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... ... California, has announced plans to release a newly redesigned website at Healthpointe.net. The ... and enhanced user experience. , The redesign serves to provide smoother interactions ...
(Date:7/31/2015)... ... July 31, 2015 , ... Physical therapy for knee osteoarthritis ... quality of life. It keeps the patient from doing what they want or need to ... a hard time using the stairs. The patient's exercise regime may be limited by the ...
(Date:7/31/2015)... ... July 31, 2015 , ... An article entitled " ... about a woman’s unfortunate experience having cosmetic skin procedures done by a family ... in blistering, swelling, bruising, and pain. This woman’s experience is only one in ...
Breaking Medicine News(10 mins):Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Healthpointe Announces Newly Redesigned Website 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3
... PORTLAND, Ore., Oct. 20 When Regence member Adrianne Johnson ... friends for recommendations, and then logged on to myRegence.com to ... were patients of those doctors. Based on the Member Reviews ... just a PCP she was comfortable with, but specialists, as ...
... Oct. 20 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... the global life sciences markets, today announced that Company shareholders ... a leading global supplier of drug discovery and life sciences ... in cash. , A Special Meeting of Shareholders was held ...
... Speaker Nancy Pelosi, House Majority Leader Steny Hoyer, ... held a press availability this afternoon in the Capitol with ... insurance reform for children with pre-existing conditions. Shannon Saunders Eaton ... Texas told their personal stories as ...
... Oct. 20 Justin Timberlake; Sam, Younes and David Nazarian; ... Cedars-Sinai Board of Governors at their annual Gala on ... in Los Angeles, California. The event, sponsored by Lexus, ... As the event sponsor, Lexus donated a 2010 Lexus LS ...
... prostate cancer the most diagnosed cancer for women and ... from these diseases, argue experts from the University of California, ... at San Antonio in an opinion piece published in the ... overall cancer rates are higher, many more patients are being ...
... ... Information and Support , ... Philadelphia, PA (Vocus) October 20, 2009 -- Keystone Mercy Health Plan, the largest ... mammography and pap smear exams, to more than 2,100 women through its Gift for ...
Cached Medicine News:Health News:Regence Takes Community Approach to Provider 'Reviews' 2Health News:Regence Takes Community Approach to Provider 'Reviews' 3Health News:MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies 2Health News:MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies 3Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 2Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 3Health News:Justin Timberlake, Sam Nazarian, Younes Nazarian, David Nazarian, Larry and Sandy Post to Be Honored at 2009 Cedars-Sinai Board of Governors Gala Sponsored By Lexus 2Health News:Experts issue call to reconsider screening for breast cancer and prostate cancer 2Health News:Experts issue call to reconsider screening for breast cancer and prostate cancer 3Health News:Experts issue call to reconsider screening for breast cancer and prostate cancer 4Health News:Experts issue call to reconsider screening for breast cancer and prostate cancer 5Health News:Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 2Health News:Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 3Health News:Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: